Do worse scores on patient-reported outcomes predict the progression of interstitial lung disease (ILD)?

M. Wijsenbeek (Rotterdam, Netherlands), P. Spagnolo (Padova, Italy), M. Kolb (Hamilton, Canada), M. Kreuter (Heidelberg , Germany), H. Nunes (Bobigny , France), W. Stansen (Ingelheim am Rhein, Germany), K. Rohr (, Ingelheim am Rhein, Germany), G. Inoue (Osaka, Japan)

Source: Virtual Congress 2021 – Interstitial lung disease around the world
Session: Interstitial lung disease around the world
Session type: E-poster
Number: 3748

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Wijsenbeek (Rotterdam, Netherlands), P. Spagnolo (Padova, Italy), M. Kolb (Hamilton, Canada), M. Kreuter (Heidelberg , Germany), H. Nunes (Bobigny , France), W. Stansen (Ingelheim am Rhein, Germany), K. Rohr (, Ingelheim am Rhein, Germany), G. Inoue (Osaka, Japan). Do worse scores on patient-reported outcomes predict the progression of interstitial lung disease (ILD)?. 3748

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The association between functional and HRQOL (K-BILD) outcome measures in IPF and other fibrotic ILDs
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016


Rheumatoid arthritis-related interstitial lung disease (RA-ILD): Clinical, functional features, and variables associated poor initial prognosis in a chilean cohort
Source: Virtual Congress 2020 – Clinical aspects and new treatment strategies for rare interstitial lung diseases in adults and children
Year: 2020

COPD related fatigue (COPD-RF) as a patient centred outcome tool in COPD: Various predictors and its correlation with other outcome parameters
Source: International Congress 2016 – Monitoring airway diseases with clinical tools
Year: 2016


Patient-reported quality of life in fibrotic interstitial lung disease: novel assessments of self-management ability and affect
Source: ERJ Open Res, 7 (1) 00011-2021; 10.1183/23120541.00011-2021
Year: 2021



Predictors of quality of life in patients with interstitial lung disease
Source: Annual Congress 2009 - Sarcoidosis and profiles of other diffuse parenchymal lung disease
Year: 2009


The composite physiological index strongly predicts mortality in interstitial lung disease (ILD) associated pulmonary hypertension (PH-ILD)
Source: International Congress 2017 – Imaging and lung disease PH
Year: 2017

Readmission in COPD patients: should we consider it a marker of quality of care or a marker of a more severe disease with a worse prognosis?
Source: Eur Respir J 2016; 48: 279-281
Year: 2016


Readmission in COPD patients: should we consider it a marker of quality of care or a marker of a more severe disease with a worse prognosis?
Source: Eur Respir J 2016; 48: 281-282
Year: 2016


Comparisons among various QOL assessments and clinical outcomes for one year in elderly patients with chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2004; 24: Suppl. 48, 66s
Year: 2004

Modified GAP index by including serum KL-6 to assess risk of disease progression in patients with interstitial lung diseases (ILD): preliminary results from the VAMOS study.
Source: Virtual Congress 2021 – New approaches to diagnostic and prognostic evaluation of interstitial lung diseases of known causes
Year: 2021



Automatic quantitative fibrosis scores at baseline is a predictor of progression in patients with IPF
Source: International Congress 2017 – Idiopathic pulmonary fibrosis (IPF): clinical problems
Year: 2017

Can clinical data predict rapid decline of lung function in idiopathic pulmonary fibrosis (IPF) patients?
Source: International Congress 2017 – IPF: from the bench to the bedside
Year: 2017

Patients' perceptions and patient-reported outcomes in progressive-fibrosing interstitial lung diseases
Source: Eur Respir Rev, 27 (150) 180075; 10.1183/16000617.0075-2018
Year: 2018



Associations between measurements of health related quality of life (HRQoL) and physical activity (PA) in patients with interstitial lung disease (ILD)
Source: Annual Congress 2012 - Assessment of physical activity, exercise, muscle function and clinical characteristics as outcomes in physiotherapy and rehabilitation
Year: 2012

Interstitial lung disease: improving classification and prognosis
Source: Virtual Congress 2021 – Clinical year in review
Year: 2021


The impact of treatment of chronic obstructive pulmonary disease (COPD) on functional status and quality of life of patients
Source: Annual Congress 2012 - COPD treatments: efficacy and safety
Year: 2012

Does health status predict survival in patients with chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2002; 20: Suppl. 38, 203s
Year: 2002

Symptoms and quality of life in relation to lung function and comorbidities in patients with idiopathic pulmonary fibrosis: INSIGHTS-IPF registry
Source: International Congress 2016 – IPF clinical
Year: 2016

Can extended hematological parameters of inflammation predict the severity and outcome of AECOPD?
Source: Virtual Congress 2020 – COPD phenotypes
Year: 2020


Markers of pulmonary vascular compromise predict survival in interstitial lung disease (ILD)
Source: Annual Congress 2008 - Clinical aspects of interstitial lung disease
Year: 2008